Canada’s largest special purpose acquisition company (SPAC) has debuted on the NEO Exchange.

On Tuesday (July 16), NEO announced that Subversive Capital Acquisition’s (NEO:SVC.UN.U) Class A restricted voting units are now available to investors.


Subversive’s initial public offering (IPO) of US$575 million made it the largest SPAC IPO in Canadian history, according to a press release. Following its qualifying transaction, Subersive’s strategy will be to “identify, acquire and … assist in the growth of a business in the cannabis industry.”

The newly organized SPAC will be the fifth one to list on the NEO and will focus its efforts on targeting businesses that are in the cannabis industry and related sectors. 

SPACs are publicly traded companies that seek capital from investors through an IPO for the purpose of acquiring an existing company. The capital raised through the IPO is put into a trust until the SPAC identifies an acquisition or merger it plans to pursue with the funds. Along with other restrictions, SPACs have a certain period of time usually 24 months within which they must complete the acquisition.

In the same press release, Leland Hensch, CEO and director at Subversive, said the company is “very excited to be listing with the leader in SPACs in Canada.”

In an interview with the Investing News Network, NEO CEO Jos Schmitt said that the size of Subversive’s IPO is an indicator that investors see “tremendous potential” in the cannabis industry.

“We’re looking at what is the largest, regardless of industry or sector … SPAC that’s ever been listed in Canada, and I think that is a token about the interest and appetite in this industry and the opportunity it represents,” said Schmitt.

He added that the cannabis sector’s relatively young age makes it a great space for SPACs, saying they are “the right vehicle, at the right moment, in the right industry.” 

One of Subversive’s partners is Michael Auerbach, who also currently acts as director at Tilray (NASDAQ:TLRY), a medical cannabis company.

Subversive filed a preliminary prospectus for an IPO last month. Its target was initially to acquire an operating business with an enterprise value between US$750 million and US$5 billion.

As mentioned, Subversive isn’t the only cannabis-focused SPAC that has launched on the NEO this year. Others have flocked to the exchange to help establish themselves in the marijuana space.

AYR Strategies (NEO:AYR.A), a multi-state operator (MSO) in the US cannabis sector, began trading on the NEO earlier this year. Previously known as SPAC Cannabis Strategies Acquisition (CSA), AYR was the first recreational cannabis-focused company with an enterprise value over C$1 billion as well as the first SPAC to list on NEO. 

The company completed its IPO as a SPAC in December 2017, initially looking to raise C$125 million to buy private cannabis companies valued between C$150 million and C$300 million, according to an article in the Globe and Mail. As a part of its qualifying transaction, CSA acquired five different cannabis businesses in Nevada and Massachusetts.

In May, Mercer Park Brand Acquisition (NEO:BRND.A.U) also began trading on the Toronto-based stock exchange after closing an IPO of US$402.5 million of Class A restricted voting units. Currently, Mercer Park holds a market cap of over C$392 million.

In addition to the cannabis SPACs, the NEO lists Canaccord Genuity Growth II (NEO:CGGZ.UN), an active SPAC from banking firm Canaccord Genuity Group (TSX:CF). The financial institution completed a transaction to merge its first SPAC, Canaccord Genuity Growth, with Columbia Care (NEO:CCHW,CCHW.WT) as a way to transfer its listing to the MSO.

Subversive currently has a market cap of C$574.43 million and its share price closed at C$9.99 on its first day of trading. On Wednesday (July 17), its share price stood at C$10.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less